carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma [published online April 4, 2018]. Leuk Lymphoma. 2018:1-7. doi: 10.1080/10428194.2018.1443337.
Advertisement
Articles by carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma [published online April 4, 2018]. Leuk Lymphoma. 2018:1-7. doi: 10.1080/10428194.2018.1443337.
Advertisement
Latest Updated Articles
- Study Summary: Ibrutinib Plus Carfilzomib for Relapsed or Relapsed/Refractory Multiple Myeloma
Published: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
CDC Reduces US Childhood Immunization Schedule From 17 to 11 Diseases
2
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
3
Nimbus Therapeutics, Eli Lilly Partner to Develop Novel Oral Metabolic Drug
4
Telemedicine Utilization and Preventive Services Among a Rural Population
5
